Product Images Medroxyprogesterone Acetate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Medroxyprogesterone Acetate NDC 69097-539 by Cipla Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
194401fa 34ec 4529 8288 ec3f845da47f 01
The text provides risk estimates for breast cancer in women who use DMPA (depot medroxyprogesterone acetate) based on several studies. The odds ratio for breast cancer in DMPA users is presented on a logarithmic scale. The text includes odds ratio and confidence interval values for five different studies, and the odds ratio for DMPA users for each study is greater than 1, meaning there is an increased risk of breast cancer. The odds ratio estimates were adjusted for different covariates in each study.*
194401fa 34ec 4529 8288 ec3f845da47f 02
194401fa 34ec 4529 8288 ec3f845da47f 03
194401fa 34ec 4529 8288 ec3f845da47f 04
This text provides information about a medication with the National Drug Code of 69097-539-31 and indicates that it is a prescription drug. The recommended dosage and use of the medication are not provided and the reader is advised to refer to the accompanying prescribing information for more details. The medication is an injectable suspension with a concentration of 150 mg/mL, and should be shaken before each use and stored upright. The medication is manufactured by Cipla Ltd. in Verna Goa, India, and is only for intramuscular use. The medication is packaged as a single-dose vial and is manufactured for Cipla USA, Inc. located in Warren, NJ.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.